1. Home
  2. TCRX vs QMCO Comparison

TCRX vs QMCO Comparison

Compare TCRX & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • QMCO
  • Stock Information
  • Founded
  • TCRX 2018
  • QMCO 1980
  • Country
  • TCRX United States
  • QMCO United States
  • Employees
  • TCRX N/A
  • QMCO N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • QMCO Electronic Components
  • Sector
  • TCRX Health Care
  • QMCO Technology
  • Exchange
  • TCRX Nasdaq
  • QMCO Nasdaq
  • Market Cap
  • TCRX 67.9M
  • QMCO 72.3M
  • IPO Year
  • TCRX 2021
  • QMCO N/A
  • Fundamental
  • Price
  • TCRX $1.44
  • QMCO $10.32
  • Analyst Decision
  • TCRX Strong Buy
  • QMCO Hold
  • Analyst Count
  • TCRX 6
  • QMCO 3
  • Target Price
  • TCRX $9.83
  • QMCO $19.00
  • AVG Volume (30 Days)
  • TCRX 520.8K
  • QMCO 831.9K
  • Earning Date
  • TCRX 05-12-2025
  • QMCO 06-16-2025
  • Dividend Yield
  • TCRX N/A
  • QMCO N/A
  • EPS Growth
  • TCRX N/A
  • QMCO N/A
  • EPS
  • TCRX N/A
  • QMCO N/A
  • Revenue
  • TCRX $2,816,000.00
  • QMCO $285,865,000.00
  • Revenue This Year
  • TCRX $47.30
  • QMCO N/A
  • Revenue Next Year
  • TCRX $74.30
  • QMCO $2.46
  • P/E Ratio
  • TCRX N/A
  • QMCO N/A
  • Revenue Growth
  • TCRX N/A
  • QMCO N/A
  • 52 Week Low
  • TCRX $1.02
  • QMCO $2.22
  • 52 Week High
  • TCRX $9.69
  • QMCO $90.64
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 49.74
  • QMCO 38.30
  • Support Level
  • TCRX $1.02
  • QMCO $10.58
  • Resistance Level
  • TCRX $1.36
  • QMCO $12.88
  • Average True Range (ATR)
  • TCRX 0.16
  • QMCO 1.41
  • MACD
  • TCRX 0.05
  • QMCO -0.10
  • Stochastic Oscillator
  • TCRX 77.78
  • QMCO 10.43

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.

Share on Social Networks: